UpHealth, Inc.'s next confirmed earnings release is scheduled for November 24, 2026.
| Earnings Date | 11/24/2026 |
As of March 31, 2024, UpHealth, Inc. has 18.81M shares outstanding.
| Shares Outstanding | 18.81M |
As of March 31, 2024, UpHealth, Inc. maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 183.29, indicating elevated leverage, while an interest coverage ratio of -3.07 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.18 |
| Quick Ratio | 0.01 |
| Debt / Equity | 183.29 |
| Debt / EBITDA | -1.82 |
| Interest Coverage | -3.07 |
Over the twelve months ended March 31, 2024, UpHealth, Inc. posted a negative return on equity (ROE) of -26.45, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -8.00, reflecting losses generated across the asset base. The company generates approximately 128,722.34 in revenue per employee across its workforce of 682.50, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -26.45 |
| Return on Assets (ROA) | -8.00 |
| Revenue Per Employee | 128,722.34 |
| Employee Count | 682.50 |
Over the twelve months ended March 31, 2024, UpHealth, Inc. recorded 3.30M in income tax expense. The company reported a pretax loss of -57.36M and -24.33M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 3.30M |
As of the close on November 13, 2026, UpHealth, Inc.'s stock has declined approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | -50.00% |
Over the twelve months ended March 31, 2024, UpHealth, Inc. generated 87.85M in revenue and converted that into -24.33M in net income, yielding earnings per share of -3.28. EBITDA reached -82.39M, while operating income came in at -3.49M.
| Revenue | 87.85M |
| Gross Profit | 46.92M |
| Operating Income | -3.49M |
| Pretax Income | -57.36M |
| Net Income | -24.33M |
| EBITDA | -82.39M |
| EBIT | -94.16M |
| Earnings Per Share (EPS) | -3.28 |
As of March 31, 2024, UpHealth, Inc. holds 955,000.00 in cash and equivalents against 149.91M in total debt, resulting in a net debt position of 148.20M. Total book value stands at 81.79M, with working capital of 26.38M providing operational flexibility.
| Cash & Cash Equivalents | 955,000.00 |
| Total Debt | 149.91M |
| Net Debt | 148.20M |
| Equity (Book Value) | 81.79M |
| Book Value Per Share | 4.35 |
| Working Capital | 26.38M |
UpHealth, Inc. produced -20.20M in operating cash flow over the twelve months ended March 31, 2024. After subtracting -3.17M in capital expenditures, free cash flow totaled -23.38M - equivalent to -1.27 per share.
| Operating Cash Flow | -20.20M |
| Capital Expenditures | -3.17M |
| Free Cash Flow | -23.38M |
| FCF Per Share | -1.27 |
Over the twelve months ended March 31, 2024, UpHealth, Inc. posted a gross margin of 53.41, reflecting its pricing power and cost economics. The operating margin of -3.98 and net profit margin of -27.70 provide insight into operational efficiency.
| Gross Margin | 53.41 |
| Operating Margin | -3.98 |
| Pretax Margin | -65.29 |
| Profit Margin | -27.70 |
| EBITDA Margin | -93.79 |
UpHealth, Inc.'s most recent stock split took place on December 9, 2022 with a 10:1 split ratio.
| Last Split Date | 12/9/2022 |
| Split Ratio | 10:1 |